ingest
cdrApp
2017-07-06T13:05:39.027Z
ccd64451-f0fc-4a42-94ad-226f4041fa4f
modifyDatastreamByValue
RELS-EXT
cdrApp
2017-07-06T13:19:15.604Z
Setting exclusive relation
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-01-25T02:47:22.735Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-01-27T03:33:19.161Z
modifyDatastreamByValue
RELS-EXT
fedoraAdmin
2018-02-08T20:51:30.045Z
Setting exclusive relation
addDatastream
MD_TECHNICAL
fedoraAdmin
2018-02-08T20:51:41.406Z
Adding technical metadata derived by FITS
addDatastream
MD_FULL_TEXT
fedoraAdmin
2018-02-08T20:52:06.825Z
Adding full text metadata extracted by Apache Tika
modifyDatastreamByValue
RELS-EXT
fedoraAdmin
2018-02-08T20:52:20.625Z
Setting exclusive relation
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-03-13T23:20:43.747Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-05-16T20:51:17.755Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-07-10T21:51:50.091Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-07-17T18:01:15.836Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-08-08T17:27:49.333Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-08-15T14:34:50.847Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-08-16T17:38:06.182Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-09-21T15:07:37.717Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-09-26T18:09:05.377Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-10-11T18:53:28.703Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2019-02-28T02:12:03.159Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2019-03-19T21:31:12.379Z
Joann
Gruber
Author
Department of Epidemiology
Gillings School of Global Public Health
Timing of rotavirus vaccination and incidence of severe rotavirus gastroenteritis among infants in low- and middle-income countries
Rotavirus vaccines effectiveness is much lower in low- and middle-income countries (LMICs) than high-income countries. Some factors associated with decreased immune response, including interference by transplacental antibodies and the microbiota, may be mitigated by altering vaccine schedules. The purpose of this dissertation was to investigate when children in LMICs experienced severe rotavirus gastroenteritis (RVGE) and if the timing of rotavirus vaccine doses was associated with severe RVGE.
We analyzed data from two clinical trials in LMICs. To understand the timing and predictors of severe RVGE, we estimated the rate, cumulative incidence, and age distribution of severe RVGE among unvaccinated infants. Cox proportional hazards models were used to estimate associations between baseline factors and severe RVGE. To estimate the association between rotavirus vaccine dose timing and severe RVGE incidence, we compared different schedules using the complement of the Kaplan-Meier estimator to estimate differences and ratios of cumulative severe RVGE risk at 6, 12, and 18 months of age and also used a Cox proportional hazards model to estimate hazard ratios. To obtain adjusted estimates, we used the associations observed in the placebo group, which should only differ from the null due to confounding, to calibrate the estimates within the rotavirus vaccinated groups.
The cumulative incidence of severe RVGE was 6 – 8 % at 20 months of age. The cumulative incidence increased steadily over the first two years of life and was low at 6 months of age. Antibiotic use was associated with about 1.4 to 2 times the rate of severe RVGE. There was a dose-response relationship between age at first pentavalent vaccine (RV5) dose and severe RVGE. Earlier administration of first RV5 dose was associated with an increased severe RVGE risk and that risk declined with increased age of first dose until approximately 8 – 9 weeks of age. An interval of 4 versus 6 weeks between monovalent vaccine (RV1) doses was associated with increased risk of severe RVGE when RV1 was administered on an approximately 10/14 week schedule. This dissertation, in conjunction with previous scientific literature, indicates severe RVGE episodes may be prevented by altering rotavirus vaccine schedules in LMICs.
Spring 2017
2017
Epidemiology
Public health
children, gastroenteritis, low- and middle-income countries, rotavirus, vaccines
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting institution
Epidemiology
Michele
Jonsson Funk
Thesis advisor
James
Thomas
Thesis advisor
M.
Brookhart
Thesis advisor
Michael
Hudgens
Thesis advisor
Sylvia
Becker-Dreps
Thesis advisor
text
Joann
Gruber
Creator
Department of Epidemiology
Gillings School of Global Public Health
Timing of rotavirus vaccination and incidence of severe rotavirus
gastroenteritis among infants in low- and middle-income countries
Rotavirus vaccines effectiveness is much lower in low- and middle-income
countries (LMICs) than high-income countries. Some factors associated with decreased
immune response, including interference by transplacental antibodies and the microbiota,
may be mitigated by altering vaccine schedules. The purpose of this dissertation was to
investigate when children in LMICs experienced severe rotavirus gastroenteritis (RVGE) and
if the timing of rotavirus vaccine doses was associated with severe RVGE. We analyzed data
from two clinical trials in LMICs. To understand the timing and predictors of severe RVGE,
we estimated the rate, cumulative incidence, and age distribution of severe RVGE among
unvaccinated infants. Cox proportional hazards models were used to estimate associations
between baseline factors and severe RVGE. To estimate the association between rotavirus
vaccine dose timing and severe RVGE incidence, we compared different schedules using the
complement of the Kaplan-Meier estimator to estimate differences and ratios of cumulative
severe RVGE risk at 6, 12, and 18 months of age and also used a Cox proportional hazards
model to estimate hazard ratios. To obtain adjusted estimates, we used the associations
observed in the placebo group, which should only differ from the null due to confounding,
to calibrate the estimates within the rotavirus vaccinated groups. The cumulative
incidence of severe RVGE was 6 – 8 % at 20 months of age. The cumulative incidence
increased steadily over the first two years of life and was low at 6 months of age.
Antibiotic use was associated with about 1.4 to 2 times the rate of severe RVGE. There was
a dose-response relationship between age at first pentavalent vaccine (RV5) dose and
severe RVGE. Earlier administration of first RV5 dose was associated with an increased
severe RVGE risk and that risk declined with increased age of first dose until
approximately 8 – 9 weeks of age. An interval of 4 versus 6 weeks between monovalent
vaccine (RV1) doses was associated with increased risk of severe RVGE when RV1 was
administered on an approximately 10/14 week schedule. This dissertation, in conjunction
with previous scientific literature, indicates severe RVGE episodes may be prevented by
altering rotavirus vaccine schedules in LMICs.
Spring 2017
2017
Epidemiology
Public health
children, gastroenteritis, low- and middle-income
countries, rotavirus, vaccines
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting
institution
Epidemiology
Michele
Jonsson Funk
Thesis advisor
James
Thomas
Thesis advisor
M.
Brookhart
Thesis advisor
Michael
Hudgens
Thesis advisor
Sylvia
Becker-Dreps
Thesis advisor
text
Joann
Gruber
Creator
Department of Epidemiology
Gillings School of Global Public Health
Timing of rotavirus vaccination and incidence of severe rotavirus gastroenteritis among infants in low- and middle-income countries
Rotavirus vaccines effectiveness is much lower in low- and middle-income countries (LMICs) than high-income countries. Some factors associated with decreased immune response, including interference by transplacental antibodies and the microbiota, may be mitigated by altering vaccine schedules. The purpose of this dissertation was to investigate when children in LMICs experienced severe rotavirus gastroenteritis (RVGE) and if the timing of rotavirus vaccine doses was associated with severe RVGE. We analyzed data from two clinical trials in LMICs. To understand the timing and predictors of severe RVGE, we estimated the rate, cumulative incidence, and age distribution of severe RVGE among unvaccinated infants. Cox proportional hazards models were used to estimate associations between baseline factors and severe RVGE. To estimate the association between rotavirus vaccine dose timing and severe RVGE incidence, we compared different schedules using the complement of the Kaplan-Meier estimator to estimate differences and ratios of cumulative severe RVGE risk at 6, 12, and 18 months of age and also used a Cox proportional hazards model to estimate hazard ratios. To obtain adjusted estimates, we used the associations observed in the placebo group, which should only differ from the null due to confounding, to calibrate the estimates within the rotavirus vaccinated groups. The cumulative incidence of severe RVGE was 6 – 8 % at 20 months of age. The cumulative incidence increased steadily over the first two years of life and was low at 6 months of age. Antibiotic use was associated with about 1.4 to 2 times the rate of severe RVGE. There was a dose-response relationship between age at first pentavalent vaccine (RV5) dose and severe RVGE. Earlier administration of first RV5 dose was associated with an increased severe RVGE risk and that risk declined with increased age of first dose until approximately 8 – 9 weeks of age. An interval of 4 versus 6 weeks between monovalent vaccine (RV1) doses was associated with increased risk of severe RVGE when RV1 was administered on an approximately 10/14 week schedule. This dissertation, in conjunction with previous scientific literature, indicates severe RVGE episodes may be prevented by altering rotavirus vaccine schedules in LMICs.
Spring 2017
2017
Epidemiology
Public health
children, gastroenteritis, low- and middle-income countries, rotavirus, vaccines
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting institution
Epidemiology
Michele
Jonsson Funk
Thesis advisor
James
Thomas
Thesis advisor
M.
Brookhart
Thesis advisor
Michael
Hudgens
Thesis advisor
Sylvia
Becker-Dreps
Thesis advisor
text
Joann
Gruber
Creator
Department of Epidemiology
Gillings School of Global Public Health
Timing of rotavirus vaccination and incidence of severe rotavirus gastroenteritis among infants in low- and middle-income countries
Rotavirus vaccines effectiveness is much lower in low- and middle-income countries (LMICs) than high-income countries. Some factors associated with decreased immune response, including interference by transplacental antibodies and the microbiota, may be mitigated by altering vaccine schedules. The purpose of this dissertation was to investigate when children in LMICs experienced severe rotavirus gastroenteritis (RVGE) and if the timing of rotavirus vaccine doses was associated with severe RVGE. We analyzed data from two clinical trials in LMICs. To understand the timing and predictors of severe RVGE, we estimated the rate, cumulative incidence, and age distribution of severe RVGE among unvaccinated infants. Cox proportional hazards models were used to estimate associations between baseline factors and severe RVGE. To estimate the association between rotavirus vaccine dose timing and severe RVGE incidence, we compared different schedules using the complement of the Kaplan-Meier estimator to estimate differences and ratios of cumulative severe RVGE risk at 6, 12, and 18 months of age and also used a Cox proportional hazards model to estimate hazard ratios. To obtain adjusted estimates, we used the associations observed in the placebo group, which should only differ from the null due to confounding, to calibrate the estimates within the rotavirus vaccinated groups. The cumulative incidence of severe RVGE was 6 – 8 % at 20 months of age. The cumulative incidence increased steadily over the first two years of life and was low at 6 months of age. Antibiotic use was associated with about 1.4 to 2 times the rate of severe RVGE. There was a dose-response relationship between age at first pentavalent vaccine (RV5) dose and severe RVGE. Earlier administration of first RV5 dose was associated with an increased severe RVGE risk and that risk declined with increased age of first dose until approximately 8 – 9 weeks of age. An interval of 4 versus 6 weeks between monovalent vaccine (RV1) doses was associated with increased risk of severe RVGE when RV1 was administered on an approximately 10/14 week schedule. This dissertation, in conjunction with previous scientific literature, indicates severe RVGE episodes may be prevented by altering rotavirus vaccine schedules in LMICs.
2017-05
2017
Epidemiology
Public health
children, gastroenteritis, low- and middle-income countries, rotavirus, vaccines
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting institution
Epidemiology
Michele
Jonsson Funk
Thesis advisor
James
Thomas
Thesis advisor
M.
Brookhart
Thesis advisor
Michael
Hudgens
Thesis advisor
Sylvia
Becker-Dreps
Thesis advisor
text
Joann
Gruber
Creator
Department of Epidemiology
Gillings School of Global Public Health
Timing of rotavirus vaccination and incidence of severe rotavirus gastroenteritis among infants in low- and middle-income countries
Rotavirus vaccines effectiveness is much lower in low- and middle-income countries (LMICs) than high-income countries. Some factors associated with decreased immune response, including interference by transplacental antibodies and the microbiota, may be mitigated by altering vaccine schedules. The purpose of this dissertation was to investigate when children in LMICs experienced severe rotavirus gastroenteritis (RVGE) and if the timing of rotavirus vaccine doses was associated with severe RVGE. We analyzed data from two clinical trials in LMICs. To understand the timing and predictors of severe RVGE, we estimated the rate, cumulative incidence, and age distribution of severe RVGE among unvaccinated infants. Cox proportional hazards models were used to estimate associations between baseline factors and severe RVGE. To estimate the association between rotavirus vaccine dose timing and severe RVGE incidence, we compared different schedules using the complement of the Kaplan-Meier estimator to estimate differences and ratios of cumulative severe RVGE risk at 6, 12, and 18 months of age and also used a Cox proportional hazards model to estimate hazard ratios. To obtain adjusted estimates, we used the associations observed in the placebo group, which should only differ from the null due to confounding, to calibrate the estimates within the rotavirus vaccinated groups. The cumulative incidence of severe RVGE was 6 – 8 % at 20 months of age. The cumulative incidence increased steadily over the first two years of life and was low at 6 months of age. Antibiotic use was associated with about 1.4 to 2 times the rate of severe RVGE. There was a dose-response relationship between age at first pentavalent vaccine (RV5) dose and severe RVGE. Earlier administration of first RV5 dose was associated with an increased severe RVGE risk and that risk declined with increased age of first dose until approximately 8 – 9 weeks of age. An interval of 4 versus 6 weeks between monovalent vaccine (RV1) doses was associated with increased risk of severe RVGE when RV1 was administered on an approximately 10/14 week schedule. This dissertation, in conjunction with previous scientific literature, indicates severe RVGE episodes may be prevented by altering rotavirus vaccine schedules in LMICs.
2017
Epidemiology
Public health
children, gastroenteritis, low- and middle-income countries, rotavirus, vaccines
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting institution
Epidemiology
Michele
Jonsson Funk
Thesis advisor
James
Thomas
Thesis advisor
M.
Brookhart
Thesis advisor
Michael
Hudgens
Thesis advisor
Sylvia
Becker-Dreps
Thesis advisor
text
2017-05
Joann
Gruber
Creator
Department of Epidemiology
Gillings School of Global Public Health
Timing of rotavirus vaccination and incidence of severe rotavirus gastroenteritis among infants in low- and middle-income countries
Rotavirus vaccines effectiveness is much lower in low- and middle-income countries (LMICs) than high-income countries. Some factors associated with decreased immune response, including interference by transplacental antibodies and the microbiota, may be mitigated by altering vaccine schedules. The purpose of this dissertation was to investigate when children in LMICs experienced severe rotavirus gastroenteritis (RVGE) and if the timing of rotavirus vaccine doses was associated with severe RVGE. We analyzed data from two clinical trials in LMICs. To understand the timing and predictors of severe RVGE, we estimated the rate, cumulative incidence, and age distribution of severe RVGE among unvaccinated infants. Cox proportional hazards models were used to estimate associations between baseline factors and severe RVGE. To estimate the association between rotavirus vaccine dose timing and severe RVGE incidence, we compared different schedules using the complement of the Kaplan-Meier estimator to estimate differences and ratios of cumulative severe RVGE risk at 6, 12, and 18 months of age and also used a Cox proportional hazards model to estimate hazard ratios. To obtain adjusted estimates, we used the associations observed in the placebo group, which should only differ from the null due to confounding, to calibrate the estimates within the rotavirus vaccinated groups. The cumulative incidence of severe RVGE was 6 – 8 % at 20 months of age. The cumulative incidence increased steadily over the first two years of life and was low at 6 months of age. Antibiotic use was associated with about 1.4 to 2 times the rate of severe RVGE. There was a dose-response relationship between age at first pentavalent vaccine (RV5) dose and severe RVGE. Earlier administration of first RV5 dose was associated with an increased severe RVGE risk and that risk declined with increased age of first dose until approximately 8 – 9 weeks of age. An interval of 4 versus 6 weeks between monovalent vaccine (RV1) doses was associated with increased risk of severe RVGE when RV1 was administered on an approximately 10/14 week schedule. This dissertation, in conjunction with previous scientific literature, indicates severe RVGE episodes may be prevented by altering rotavirus vaccine schedules in LMICs.
2017
Epidemiology
Public health
children, gastroenteritis, low- and middle-income countries, rotavirus, vaccines
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting institution
Epidemiology
Michele
Jonsson Funk
Thesis advisor
James
Thomas
Thesis advisor
M.
Brookhart
Thesis advisor
Michael
Hudgens
Thesis advisor
Sylvia
Becker-Dreps
Thesis advisor
text
2017-05
Joann
Gruber
Creator
Department of Epidemiology
Gillings School of Global Public Health
Timing of rotavirus vaccination and incidence of severe rotavirus gastroenteritis among infants in low- and middle-income countries
Rotavirus vaccines effectiveness is much lower in low- and middle-income countries (LMICs) than high-income countries. Some factors associated with decreased immune response, including interference by transplacental antibodies and the microbiota, may be mitigated by altering vaccine schedules. The purpose of this dissertation was to investigate when children in LMICs experienced severe rotavirus gastroenteritis (RVGE) and if the timing of rotavirus vaccine doses was associated with severe RVGE. We analyzed data from two clinical trials in LMICs. To understand the timing and predictors of severe RVGE, we estimated the rate, cumulative incidence, and age distribution of severe RVGE among unvaccinated infants. Cox proportional hazards models were used to estimate associations between baseline factors and severe RVGE. To estimate the association between rotavirus vaccine dose timing and severe RVGE incidence, we compared different schedules using the complement of the Kaplan-Meier estimator to estimate differences and ratios of cumulative severe RVGE risk at 6, 12, and 18 months of age and also used a Cox proportional hazards model to estimate hazard ratios. To obtain adjusted estimates, we used the associations observed in the placebo group, which should only differ from the null due to confounding, to calibrate the estimates within the rotavirus vaccinated groups. The cumulative incidence of severe RVGE was 6 – 8 % at 20 months of age. The cumulative incidence increased steadily over the first two years of life and was low at 6 months of age. Antibiotic use was associated with about 1.4 to 2 times the rate of severe RVGE. There was a dose-response relationship between age at first pentavalent vaccine (RV5) dose and severe RVGE. Earlier administration of first RV5 dose was associated with an increased severe RVGE risk and that risk declined with increased age of first dose until approximately 8 – 9 weeks of age. An interval of 4 versus 6 weeks between monovalent vaccine (RV1) doses was associated with increased risk of severe RVGE when RV1 was administered on an approximately 10/14 week schedule. This dissertation, in conjunction with previous scientific literature, indicates severe RVGE episodes may be prevented by altering rotavirus vaccine schedules in LMICs.
2017
Epidemiology
Public health
children, gastroenteritis, low- and middle-income countries, rotavirus, vaccines
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting institution
Epidemiology
Michele
Jonsson Funk
Thesis advisor
James
Thomas
Thesis advisor
M.
Brookhart
Thesis advisor
Michael
Hudgens
Thesis advisor
Sylvia
Becker-Dreps
Thesis advisor
text
2017-05
Joann
Gruber
Creator
Department of Epidemiology
Gillings School of Global Public Health
Timing of rotavirus vaccination and incidence of severe rotavirus gastroenteritis among infants in low- and middle-income countries
Rotavirus vaccines effectiveness is much lower in low- and middle-income countries (LMICs) than high-income countries. Some factors associated with decreased immune response, including interference by transplacental antibodies and the microbiota, may be mitigated by altering vaccine schedules. The purpose of this dissertation was to investigate when children in LMICs experienced severe rotavirus gastroenteritis (RVGE) and if the timing of rotavirus vaccine doses was associated with severe RVGE. We analyzed data from two clinical trials in LMICs. To understand the timing and predictors of severe RVGE, we estimated the rate, cumulative incidence, and age distribution of severe RVGE among unvaccinated infants. Cox proportional hazards models were used to estimate associations between baseline factors and severe RVGE. To estimate the association between rotavirus vaccine dose timing and severe RVGE incidence, we compared different schedules using the complement of the Kaplan-Meier estimator to estimate differences and ratios of cumulative severe RVGE risk at 6, 12, and 18 months of age and also used a Cox proportional hazards model to estimate hazard ratios. To obtain adjusted estimates, we used the associations observed in the placebo group, which should only differ from the null due to confounding, to calibrate the estimates within the rotavirus vaccinated groups. The cumulative incidence of severe RVGE was 6 – 8 % at 20 months of age. The cumulative incidence increased steadily over the first two years of life and was low at 6 months of age. Antibiotic use was associated with about 1.4 to 2 times the rate of severe RVGE. There was a dose-response relationship between age at first pentavalent vaccine (RV5) dose and severe RVGE. Earlier administration of first RV5 dose was associated with an increased severe RVGE risk and that risk declined with increased age of first dose until approximately 8 – 9 weeks of age. An interval of 4 versus 6 weeks between monovalent vaccine (RV1) doses was associated with increased risk of severe RVGE when RV1 was administered on an approximately 10/14 week schedule. This dissertation, in conjunction with previous scientific literature, indicates severe RVGE episodes may be prevented by altering rotavirus vaccine schedules in LMICs.
2017
Epidemiology
Public health
children, gastroenteritis, low- and middle-income countries, rotavirus, vaccines
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting institution
Epidemiology
Michele
Jonsson Funk
Thesis advisor
James C.
Thomas
Thesis advisor
M. Alan
Brookhart
Thesis advisor
Michael
Hudgens
Thesis advisor
Sylvia
Becker-Dreps
Thesis advisor
text
2017-05
Joann
Gruber
Creator
Department of Epidemiology
Gillings School of Global Public Health
Timing of rotavirus vaccination and incidence of severe rotavirus gastroenteritis among infants in low- and middle-income countries
Rotavirus vaccines effectiveness is much lower in low- and middle-income countries (LMICs) than high-income countries. Some factors associated with decreased immune response, including interference by transplacental antibodies and the microbiota, may be mitigated by altering vaccine schedules. The purpose of this dissertation was to investigate when children in LMICs experienced severe rotavirus gastroenteritis (RVGE) and if the timing of rotavirus vaccine doses was associated with severe RVGE. We analyzed data from two clinical trials in LMICs. To understand the timing and predictors of severe RVGE, we estimated the rate, cumulative incidence, and age distribution of severe RVGE among unvaccinated infants. Cox proportional hazards models were used to estimate associations between baseline factors and severe RVGE. To estimate the association between rotavirus vaccine dose timing and severe RVGE incidence, we compared different schedules using the complement of the Kaplan-Meier estimator to estimate differences and ratios of cumulative severe RVGE risk at 6, 12, and 18 months of age and also used a Cox proportional hazards model to estimate hazard ratios. To obtain adjusted estimates, we used the associations observed in the placebo group, which should only differ from the null due to confounding, to calibrate the estimates within the rotavirus vaccinated groups. The cumulative incidence of severe RVGE was 6 – 8 % at 20 months of age. The cumulative incidence increased steadily over the first two years of life and was low at 6 months of age. Antibiotic use was associated with about 1.4 to 2 times the rate of severe RVGE. There was a dose-response relationship between age at first pentavalent vaccine (RV5) dose and severe RVGE. Earlier administration of first RV5 dose was associated with an increased severe RVGE risk and that risk declined with increased age of first dose until approximately 8 – 9 weeks of age. An interval of 4 versus 6 weeks between monovalent vaccine (RV1) doses was associated with increased risk of severe RVGE when RV1 was administered on an approximately 10/14 week schedule. This dissertation, in conjunction with previous scientific literature, indicates severe RVGE episodes may be prevented by altering rotavirus vaccine schedules in LMICs.
2017
Epidemiology
Public health
children, gastroenteritis, low- and middle-income countries, rotavirus, vaccines
eng
Doctor of Philosophy
Dissertation
Epidemiology
Michele
Jonsson Funk
Thesis advisor
James C.
Thomas
Thesis advisor
M. Alan
Brookhart
Thesis advisor
Michael
Hudgens
Thesis advisor
Sylvia
Becker-Dreps
Thesis advisor
text
2017-05
University of North Carolina at Chapel Hill
Degree granting institution
Joann
Gruber
Creator
Department of Epidemiology
Gillings School of Global Public Health
Timing of rotavirus vaccination and incidence of severe rotavirus gastroenteritis among infants in low- and middle-income countries
Rotavirus vaccines effectiveness is much lower in low- and middle-income countries (LMICs) than high-income countries. Some factors associated with decreased immune response, including interference by transplacental antibodies and the microbiota, may be mitigated by altering vaccine schedules. The purpose of this dissertation was to investigate when children in LMICs experienced severe rotavirus gastroenteritis (RVGE) and if the timing of rotavirus vaccine doses was associated with severe RVGE. We analyzed data from two clinical trials in LMICs. To understand the timing and predictors of severe RVGE, we estimated the rate, cumulative incidence, and age distribution of severe RVGE among unvaccinated infants. Cox proportional hazards models were used to estimate associations between baseline factors and severe RVGE. To estimate the association between rotavirus vaccine dose timing and severe RVGE incidence, we compared different schedules using the complement of the Kaplan-Meier estimator to estimate differences and ratios of cumulative severe RVGE risk at 6, 12, and 18 months of age and also used a Cox proportional hazards model to estimate hazard ratios. To obtain adjusted estimates, we used the associations observed in the placebo group, which should only differ from the null due to confounding, to calibrate the estimates within the rotavirus vaccinated groups. The cumulative incidence of severe RVGE was 6 – 8 % at 20 months of age. The cumulative incidence increased steadily over the first two years of life and was low at 6 months of age. Antibiotic use was associated with about 1.4 to 2 times the rate of severe RVGE. There was a dose-response relationship between age at first pentavalent vaccine (RV5) dose and severe RVGE. Earlier administration of first RV5 dose was associated with an increased severe RVGE risk and that risk declined with increased age of first dose until approximately 8 – 9 weeks of age. An interval of 4 versus 6 weeks between monovalent vaccine (RV1) doses was associated with increased risk of severe RVGE when RV1 was administered on an approximately 10/14 week schedule. This dissertation, in conjunction with previous scientific literature, indicates severe RVGE episodes may be prevented by altering rotavirus vaccine schedules in LMICs.
2017
Epidemiology
Public health
children, gastroenteritis, low- and middle-income countries, rotavirus, vaccines
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting institution
Epidemiology
Michele
Jonsson Funk
Thesis advisor
James
Thomas
Thesis advisor
M.
Brookhart
Thesis advisor
Michael
Hudgens
Thesis advisor
Sylvia
Becker-Dreps
Thesis advisor
text
2017-05
Joann
Gruber
Creator
Department of Epidemiology
Gillings School of Global Public Health
Timing of rotavirus vaccination and incidence of severe rotavirus gastroenteritis among infants in low- and middle-income countries
Rotavirus vaccines effectiveness is much lower in low- and middle-income countries (LMICs) than high-income countries. Some factors associated with decreased immune response, including interference by transplacental antibodies and the microbiota, may be mitigated by altering vaccine schedules. The purpose of this dissertation was to investigate when children in LMICs experienced severe rotavirus gastroenteritis (RVGE) and if the timing of rotavirus vaccine doses was associated with severe RVGE. We analyzed data from two clinical trials in LMICs. To understand the timing and predictors of severe RVGE, we estimated the rate, cumulative incidence, and age distribution of severe RVGE among unvaccinated infants. Cox proportional hazards models were used to estimate associations between baseline factors and severe RVGE. To estimate the association between rotavirus vaccine dose timing and severe RVGE incidence, we compared different schedules using the complement of the Kaplan-Meier estimator to estimate differences and ratios of cumulative severe RVGE risk at 6, 12, and 18 months of age and also used a Cox proportional hazards model to estimate hazard ratios. To obtain adjusted estimates, we used the associations observed in the placebo group, which should only differ from the null due to confounding, to calibrate the estimates within the rotavirus vaccinated groups. The cumulative incidence of severe RVGE was 6 – 8 % at 20 months of age. The cumulative incidence increased steadily over the first two years of life and was low at 6 months of age. Antibiotic use was associated with about 1.4 to 2 times the rate of severe RVGE. There was a dose-response relationship between age at first pentavalent vaccine (RV5) dose and severe RVGE. Earlier administration of first RV5 dose was associated with an increased severe RVGE risk and that risk declined with increased age of first dose until approximately 8 – 9 weeks of age. An interval of 4 versus 6 weeks between monovalent vaccine (RV1) doses was associated with increased risk of severe RVGE when RV1 was administered on an approximately 10/14 week schedule. This dissertation, in conjunction with previous scientific literature, indicates severe RVGE episodes may be prevented by altering rotavirus vaccine schedules in LMICs.
2017
Epidemiology
Public health
children, gastroenteritis, low- and middle-income countries, rotavirus, vaccines
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting institution
Epidemiology
Michele
Jonsson Funk
Thesis advisor
James
Thomas
Thesis advisor
M.
Brookhart
Thesis advisor
Michael
Hudgens
Thesis advisor
Sylvia
Becker-Dreps
Thesis advisor
text
2017-05
Joann
Gruber
Creator
Department of Epidemiology
Gillings School of Global Public Health
Timing of rotavirus vaccination and incidence of severe rotavirus gastroenteritis among infants in low- and middle-income countries
Rotavirus vaccines effectiveness is much lower in low- and middle-income countries (LMICs) than high-income countries. Some factors associated with decreased immune response, including interference by transplacental antibodies and the microbiota, may be mitigated by altering vaccine schedules. The purpose of this dissertation was to investigate when children in LMICs experienced severe rotavirus gastroenteritis (RVGE) and if the timing of rotavirus vaccine doses was associated with severe RVGE. We analyzed data from two clinical trials in LMICs. To understand the timing and predictors of severe RVGE, we estimated the rate, cumulative incidence, and age distribution of severe RVGE among unvaccinated infants. Cox proportional hazards models were used to estimate associations between baseline factors and severe RVGE. To estimate the association between rotavirus vaccine dose timing and severe RVGE incidence, we compared different schedules using the complement of the Kaplan-Meier estimator to estimate differences and ratios of cumulative severe RVGE risk at 6, 12, and 18 months of age and also used a Cox proportional hazards model to estimate hazard ratios. To obtain adjusted estimates, we used the associations observed in the placebo group, which should only differ from the null due to confounding, to calibrate the estimates within the rotavirus vaccinated groups. The cumulative incidence of severe RVGE was 6 – 8 % at 20 months of age. The cumulative incidence increased steadily over the first two years of life and was low at 6 months of age. Antibiotic use was associated with about 1.4 to 2 times the rate of severe RVGE. There was a dose-response relationship between age at first pentavalent vaccine (RV5) dose and severe RVGE. Earlier administration of first RV5 dose was associated with an increased severe RVGE risk and that risk declined with increased age of first dose until approximately 8 – 9 weeks of age. An interval of 4 versus 6 weeks between monovalent vaccine (RV1) doses was associated with increased risk of severe RVGE when RV1 was administered on an approximately 10/14 week schedule. This dissertation, in conjunction with previous scientific literature, indicates severe RVGE episodes may be prevented by altering rotavirus vaccine schedules in LMICs.
2017
Epidemiology
Public health
children; gastroenteritis; low- and middle-income countries; rotavirus; vaccines
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting institution
Epidemiology
Michele
Jonsson Funk
Thesis advisor
James
Thomas
Thesis advisor
M.
Brookhart
Thesis advisor
Michael
Hudgens
Thesis advisor
Sylvia
Becker-Dreps
Thesis advisor
text
2017-05
Joann
Gruber
Creator
Department of Epidemiology
Gillings School of Global Public Health
Timing of rotavirus vaccination and incidence of severe rotavirus gastroenteritis among infants in low- and middle-income countries
Rotavirus vaccines effectiveness is much lower in low- and middle-income countries (LMICs) than high-income countries. Some factors associated with decreased immune response, including interference by transplacental antibodies and the microbiota, may be mitigated by altering vaccine schedules. The purpose of this dissertation was to investigate when children in LMICs experienced severe rotavirus gastroenteritis (RVGE) and if the timing of rotavirus vaccine doses was associated with severe RVGE. We analyzed data from two clinical trials in LMICs. To understand the timing and predictors of severe RVGE, we estimated the rate, cumulative incidence, and age distribution of severe RVGE among unvaccinated infants. Cox proportional hazards models were used to estimate associations between baseline factors and severe RVGE. To estimate the association between rotavirus vaccine dose timing and severe RVGE incidence, we compared different schedules using the complement of the Kaplan-Meier estimator to estimate differences and ratios of cumulative severe RVGE risk at 6, 12, and 18 months of age and also used a Cox proportional hazards model to estimate hazard ratios. To obtain adjusted estimates, we used the associations observed in the placebo group, which should only differ from the null due to confounding, to calibrate the estimates within the rotavirus vaccinated groups. The cumulative incidence of severe RVGE was 6 – 8 % at 20 months of age. The cumulative incidence increased steadily over the first two years of life and was low at 6 months of age. Antibiotic use was associated with about 1.4 to 2 times the rate of severe RVGE. There was a dose-response relationship between age at first pentavalent vaccine (RV5) dose and severe RVGE. Earlier administration of first RV5 dose was associated with an increased severe RVGE risk and that risk declined with increased age of first dose until approximately 8 – 9 weeks of age. An interval of 4 versus 6 weeks between monovalent vaccine (RV1) doses was associated with increased risk of severe RVGE when RV1 was administered on an approximately 10/14 week schedule. This dissertation, in conjunction with previous scientific literature, indicates severe RVGE episodes may be prevented by altering rotavirus vaccine schedules in LMICs.
2017
Epidemiology
Public health
children, gastroenteritis, low- and middle-income countries, rotavirus, vaccines
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting institution
Epidemiology
Michele
Jonsson Funk
Thesis advisor
James C.
Thomas
Thesis advisor
M. Alan
Brookhart
Thesis advisor
Michael
Hudgens
Thesis advisor
Sylvia
Becker-Dreps
Thesis advisor
text
2017-05
Joann
Gruber
Creator
Department of Epidemiology
Gillings School of Global Public Health
Timing of rotavirus vaccination and incidence of severe rotavirus gastroenteritis among infants in low- and middle-income countries
Rotavirus vaccines effectiveness is much lower in low- and middle-income countries (LMICs) than high-income countries. Some factors associated with decreased immune response, including interference by transplacental antibodies and the microbiota, may be mitigated by altering vaccine schedules. The purpose of this dissertation was to investigate when children in LMICs experienced severe rotavirus gastroenteritis (RVGE) and if the timing of rotavirus vaccine doses was associated with severe RVGE. We analyzed data from two clinical trials in LMICs. To understand the timing and predictors of severe RVGE, we estimated the rate, cumulative incidence, and age distribution of severe RVGE among unvaccinated infants. Cox proportional hazards models were used to estimate associations between baseline factors and severe RVGE. To estimate the association between rotavirus vaccine dose timing and severe RVGE incidence, we compared different schedules using the complement of the Kaplan-Meier estimator to estimate differences and ratios of cumulative severe RVGE risk at 6, 12, and 18 months of age and also used a Cox proportional hazards model to estimate hazard ratios. To obtain adjusted estimates, we used the associations observed in the placebo group, which should only differ from the null due to confounding, to calibrate the estimates within the rotavirus vaccinated groups. The cumulative incidence of severe RVGE was 6 – 8 % at 20 months of age. The cumulative incidence increased steadily over the first two years of life and was low at 6 months of age. Antibiotic use was associated with about 1.4 to 2 times the rate of severe RVGE. There was a dose-response relationship between age at first pentavalent vaccine (RV5) dose and severe RVGE. Earlier administration of first RV5 dose was associated with an increased severe RVGE risk and that risk declined with increased age of first dose until approximately 8 – 9 weeks of age. An interval of 4 versus 6 weeks between monovalent vaccine (RV1) doses was associated with increased risk of severe RVGE when RV1 was administered on an approximately 10/14 week schedule. This dissertation, in conjunction with previous scientific literature, indicates severe RVGE episodes may be prevented by altering rotavirus vaccine schedules in LMICs.
2017
Epidemiology
Public health
children; gastroenteritis; low- and middle-income countries; rotavirus; vaccines
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting institution
Epidemiology
Michele
Jonsson Funk
Thesis advisor
James C.
Thomas
Thesis advisor
M. Alan
Brookhart
Thesis advisor
Michael
Hudgens
Thesis advisor
Sylvia
Becker-Dreps
Thesis advisor
text
2017-05
Joann
Gruber
Creator
Department of Epidemiology
Gillings School of Global Public Health
Timing of rotavirus vaccination and incidence of severe rotavirus gastroenteritis among infants in low- and middle-income countries
Rotavirus vaccines effectiveness is much lower in low- and middle-income countries (LMICs) than high-income countries. Some factors associated with decreased immune response, including interference by transplacental antibodies and the microbiota, may be mitigated by altering vaccine schedules. The purpose of this dissertation was to investigate when children in LMICs experienced severe rotavirus gastroenteritis (RVGE) and if the timing of rotavirus vaccine doses was associated with severe RVGE. We analyzed data from two clinical trials in LMICs. To understand the timing and predictors of severe RVGE, we estimated the rate, cumulative incidence, and age distribution of severe RVGE among unvaccinated infants. Cox proportional hazards models were used to estimate associations between baseline factors and severe RVGE. To estimate the association between rotavirus vaccine dose timing and severe RVGE incidence, we compared different schedules using the complement of the Kaplan-Meier estimator to estimate differences and ratios of cumulative severe RVGE risk at 6, 12, and 18 months of age and also used a Cox proportional hazards model to estimate hazard ratios. To obtain adjusted estimates, we used the associations observed in the placebo group, which should only differ from the null due to confounding, to calibrate the estimates within the rotavirus vaccinated groups. The cumulative incidence of severe RVGE was 6 – 8 % at 20 months of age. The cumulative incidence increased steadily over the first two years of life and was low at 6 months of age. Antibiotic use was associated with about 1.4 to 2 times the rate of severe RVGE. There was a dose-response relationship between age at first pentavalent vaccine (RV5) dose and severe RVGE. Earlier administration of first RV5 dose was associated with an increased severe RVGE risk and that risk declined with increased age of first dose until approximately 8 – 9 weeks of age. An interval of 4 versus 6 weeks between monovalent vaccine (RV1) doses was associated with increased risk of severe RVGE when RV1 was administered on an approximately 10/14 week schedule. This dissertation, in conjunction with previous scientific literature, indicates severe RVGE episodes may be prevented by altering rotavirus vaccine schedules in LMICs.
2017
Epidemiology
Public health
children; gastroenteritis; low- and middle-income countries; rotavirus; vaccines
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting institution
Michele
Jonsson Funk
Thesis advisor
James C.
Thomas
Thesis advisor
M. Alan
Brookhart
Thesis advisor
Michael
Hudgens
Thesis advisor
Sylvia
Becker-Dreps
Thesis advisor
text
2017-05
Gruber_unc_0153D_16889.pdf
uuid:6b5fc93c-b98d-4c34-a225-b37c80e08b95
2017-04-17T19:06:30Z
2019-07-06T00:00:00
proquest
yes
application/pdf
2871242